Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.05/sh

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.05). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $8.07 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Palo Alto Networks (PANW) PT Raised to $400 at TD Cowen
• JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral